Why does Oxford vaccine generate a lot of interest?
University of Oxford has been working on vaccines on MERS (Middle East Respiratory Syndrome) and Severe Acute Respiratory Syndrome (SARS) diseases, which are caused by corona viruses.
So, it immediately jumped into the fray to develop a COVID-19 vaccine as soon as it saw the outbreak. This gave it a lead time over other vaccine makers.
The potential vaccine is already in large-scale phase III human trials to assess whether it can protect against COVID-19.
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, according to data published on Monday, July 20, 2020.
The vaccine, called A Z D 1222 and being developed by pharmaceutical company AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
“We hope this means the immune system will remember the virus, so that our vaccine will protect people for an extended period,” said the study lead author Andrew Pollard of the University of Oxford.
Credits & Thanks
Videos : Pexels.com
Picture : freepik.com
Music : Jees Prakash Musick/YouTube Audio Library
Info Sources : BBC News/moneycontrol.com/NDTV
Do Share With Your Friends
